These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


159 related items for PubMed ID: 21847882

  • 1. The ban on "off-label" pharmaceutical promotion: constitutionally permissible prophylaxis against false or misleading commercial speech?
    Greenwood K.
    Am J Law Med; 2011; 37(2-3):278-98. PubMed ID: 21847882
    [Abstract] [Full Text] [Related]

  • 2. Evaluating promotional claims as false or misleading.
    Brushwood DB, Knox CA, Liu W, Jenkins KA.
    Am J Health Syst Pharm; 2013 Nov 01; 70(21):1941-4. PubMed ID: 24128969
    [Abstract] [Full Text] [Related]

  • 3. United States v. Caronia: The increasing strength of commercial free speech and potential new emphasis on classifying off-label promotion as "false and misleading".
    Scheineson MJ, Cuevas G.
    Food Drug Law J; 2013 Nov 01; 68(2):201-16, iii. PubMed ID: 24640469
    [Abstract] [Full Text] [Related]

  • 4. Truth, Falsity, and Fraud: Off-Label Drug Settlements and the Future of the Civil False Claims Act.
    Krause JH.
    Food Drug Law J; 2016 Nov 01; 71(3):401-40. PubMed ID: 29140064
    [Abstract] [Full Text] [Related]

  • 5. United States v. Caronia: Off-Label Drug Promotion and First Amendment Balancing.
    Rabinowitz DP.
    Fordham Law Rev; 2018 Apr 01; 86(5):2595-623. PubMed ID: 29993225
    [Abstract] [Full Text] [Related]

  • 6. Commercial speech and off-label drug uses: what role for wide acceptance, general recognition and research incentives?
    Gilhooley M.
    Am J Law Med; 2011 Apr 01; 37(2-3):258-77. PubMed ID: 21847881
    [Abstract] [Full Text] [Related]

  • 7. Manufacturers' promotion of off-label drug use: implications for drug safety.
    Zieve A, Carome MA.
    Expert Opin Drug Saf; 2016 Sep 01; 15(9):1149-51. PubMed ID: 27145440
    [No Abstract] [Full Text] [Related]

  • 8. Off-label prescription advertising, the FDA and the First Amendment: a study in the values of commercial speech protection.
    Klasmeier C, Redish MH.
    Am J Law Med; 2011 Sep 01; 37(2-3):315-57. PubMed ID: 21847884
    [No Abstract] [Full Text] [Related]

  • 9. Off-label drug use and promotion: balancing public health goals and commercial speech.
    Kesselheim AS.
    Am J Law Med; 2011 Sep 01; 37(2-3):225-57. PubMed ID: 21847880
    [No Abstract] [Full Text] [Related]

  • 10. Origins of the prohibition against off-label promotion.
    Coleman TS.
    Food Drug Law J; 2014 Sep 01; 69(2):161-236, i. PubMed ID: 25163210
    [Abstract] [Full Text] [Related]

  • 11. Prospects for Enforcing Prohibitions on Off-Label Drug Promotion after United States v. Caronia: An Analysis of Litigated Cases.
    Liu S, Mello MM, Kesselheim AS.
    J Health Polit Policy Law; 2021 Jun 01; 46(3):487-504. PubMed ID: 33647951
    [Abstract] [Full Text] [Related]

  • 12. Off-label promotion: government theories of prosecution and facts that drive them.
    Burroughs AD, Levy MC, Schwab GG, Paik Y.
    Food Drug Law J; 2010 Jun 01; 65(3):555-88. PubMed ID: 24479242
    [No Abstract] [Full Text] [Related]

  • 13. Hidden truth: The perils and protection of off-label drug and medical device promotion.
    Conko G.
    Health Matrix Clevel; 2011 Jun 01; 21(1):149-87. PubMed ID: 21847900
    [No Abstract] [Full Text] [Related]

  • 14. False Claims Act prosecution did not deter off-label drug use in the case of neurontin.
    Kesselheim AS, Darby D, Studdert DM, Glynn R, Levin R, Avorn J.
    Health Aff (Millwood); 2011 Dec 01; 30(12):2318-27. PubMed ID: 22147859
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The federal regulation of prescription drug advertising and promotion.
    Kessler DA, Pines WL.
    JAMA; 1990 Nov 14; 264(18):2409-15. PubMed ID: 2231998
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.